Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT01655641
What this trial is testing

Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery

Who this might be right for
Gastric CancerPancreatic CancerHepatocellular Cancer+1 more
Tribhuvan University Teaching Hospital, Institute Of Medicine. 118
Large-scale testing (Phase 3)UnknownNCT02646137
What this trial is testing

Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma

Who this might be right for
Liver Cancer
Sherief Abd-Elsalam 50
Large-scale testing (Phase 3)Ended earlyNCT04246177
What this trial is testing

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 480
Large-scale testing (Phase 3)UnknownNCT02767375
What this trial is testing

Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After Resection

Who this might be right for
Hepatocellular Carcinoma
Peking University Cancer Hospital & Institute 192
Early research (Phase 1)Study completedNCT00960557
What this trial is testing

Safety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hepatic Tumor Burden

Who this might be right for
Neoplasm Metastasis
Mateon Therapeutics 16
Not applicableStudy completedNCT04627012
What this trial is testing

Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaAnti-PD1 AntibodyLiver Diseases
Sun Yat-sen University 600
Early research (Phase 1)Study completedNCT03993327
What this trial is testing

An Imaging Agent (I-124 M5A) in Detecting CEA-Positive Liver Metastases in Patients With Colorectal Cancer

Who this might be right for
Colorectal Carcinoma Metastatic in the LiverMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+3 more
City of Hope Medical Center 4
Not applicableUnknownNCT05205629
What this trial is testing

A Real-world Study of Donafenib Combined With TACE-based Treatment in Patients With Unresectable HCC

Who this might be right for
Hepatocellular CarcinomaDonafenib
Shanghai Zhongshan Hospital 150
Not applicableStudy completedNCT02722395
What this trial is testing

Magnetic Resonance Imaging (MRI) Solely For Liver Stereotactic Body Radiation Therapy (SBRT)

Who this might be right for
Primary Liver CancerMetastatic Liver Cancer From Any Cancer Site
Duke University 5
Not applicableWithdrawnNCT03452553
What this trial is testing

Study in the Treatment of HCC With a Radiopaque (RO) Bead (LC Bead LUMI™) Loaded With Doxorubicin

Who this might be right for
Hepatocellular Carcinoma (HCC)
Boston Scientific Corporation
Not applicableLooking for participantsNCT06877637
What this trial is testing

On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer

Who this might be right for
Hepatocellular Carcinoma (HCC)Cholangiocarcinoma
Region Skane 150
Early research (Phase 1)Study completedNCT03474640
What this trial is testing

Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies

Who this might be right for
Advanced Malignancies
TopAlliance Biosciences 184
Early research (Phase 1)Active Not RecruitingNCT04658147
What this trial is testing

Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 31
Not applicableLooking for participantsNCT04190849
What this trial is testing

European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-alcoholic Fatty LiverNon-alcoholic Steatohepatitis
Cambridge University Hospitals NHS Foundation Trust 2,000
Not applicableLooking for participantsNCT05199259
What this trial is testing

Multi-analyte Blood Test Clinical Trial

Who this might be right for
Liver CirrhosisLiver CancerHCC+1 more
Helio Genomics 1,200
Early research (Phase 1)Study completedNCT06310590
What this trial is testing

Safety and Efficacy of TareSphere in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular Carcinoma
Chengdu New Radiomedicine Technology Co. LTD. 40
Not applicableStudy completedNCT02582918
What this trial is testing

Texas Hepatocellular Carcinoma Consortium (THCCC) Project 5

Who this might be right for
Carcinoma, HepatocellularLiver Neoplasms
University of Texas Southwestern Medical Center 2,871
Testing effectiveness (Phase 2)Active Not RecruitingNCT02519348
What this trial is testing

Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
MedImmune LLC 433
Testing effectiveness (Phase 2)Looking for participantsNCT07479485
What this trial is testing

MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)

Who this might be right for
Hepatocellular Carcinoma
Lepu Biopharma Co., Ltd. 160
Testing effectiveness (Phase 2)Study completedNCT03058289
What this trial is testing

A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6

Who this might be right for
Breast CancerHead and Neck CancerSquamous Cell Carcinoma+8 more
Intensity Therapeutics, Inc. 111
Next Page